Dysfunction of cholinergic neurotransmission has been implicated in neurological disorders such as Alzheimer's disease, and attempts have been made to use cognitive enhancer such as acetylcholinesterase inhibitors to combat dementia (43–45). This evidence concerns the gene ACHE and Alzheimer disease.